FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thomas Bechtel

Research Profile

Chemicals & Drugs

Procedures

Disorders

Concepts & Ideas

Area Under Curve

Co-author Network

Publications

TOP 3
Mehdi Hamadani; William Blum; Gary Phillips; Patrick J Elder; Leslie Andritsos; Craig C Hofmeister; Lynn O'Donnell; Rebecca B Klisovic; Sam Penza; Ramiro Garzon; David Krugh; Thomas Lin; Thomas Bechtel; Don M Benson; John C Byrd; Guido Marcucci; Steven M Devine
Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignancies.
Casey B Williams; Suzanne D Day; Michael D Reed; Edward A Copelan; Thomas Bechtel; Helen L Leather; John R Wingard; Brian L Abbott; Sunil Abhyankar; Joseph P McGuirk
Dose modification protocol using intravenous busulfan (Busulfex) and cyclophosphamide followed by autologous or allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies.
Edward A Copelan; Stacy Hoshaw-Woodard; Patrick J Elder; Sam Penza; Sherif S Farag; Guido Marcucci; Thomas Lin; SA Ezzone; MD Scholl; Thomas Bechtel; Stanley Lemeshow; Belinda R Avalos
Therapy-related myelodysplasia and leukemia occur infrequently following VP-16 priming and autotransplantation without total body irradiation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thomas Bechtel (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Mehdi Hamadani; William Blum; Gary Phillips; Patrick J Elder; Leslie Andritsos; Craig C Hofmeister; Lynn O'Donnell; Rebecca B Klisovic; Sam Penza; Ramiro Garzon; David Krugh; Thomas Lin; Thomas Bechtel; Don M Benson; John C Byrd; Guido Marcucci; Steven M Devine
Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(11):1422-30.
2004: Casey B Williams; Suzanne D Day; Michael D Reed; Edward A Copelan; Thomas Bechtel; Helen L Leather; John R Wingard; Brian L Abbott; Sunil Abhyankar; Joseph P McGuirk
Dose modification protocol using intravenous busulfan (Busulfex) and cyclophosphamide followed by autologous or allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(9):614-23.
2004: Edward A Copelan; Stacy Hoshaw-Woodard; Patrick J Elder; Sam Penza; Sherif S Farag; Guido Marcucci; Thomas Lin; SA Ezzone; MD Scholl; Thomas Bechtel; Stanley Lemeshow; Belinda R Avalos
Therapy-related myelodysplasia and leukemia occur infrequently following VP-16 priming and autotransplantation without total body irradiation.
Bone marrow transplantation 2004;34(1):85-7.
2001: Edward A Copelan; Thomas Bechtel; Belinda R Avalos; Patrick J Elder; SA Ezzone; MD Scholl; Sam Penza
Busulfan levels are influenced by prior treatment and are associated with hepatic veno-occlusive disease and early mortality but not with delayed complications following marrow transplantation.
Bone marrow transplantation 2001;27(11):1121-4.
2000: Edward A Copelan; Sam Penza; Karl S Theil; Patrick J Elder; Thomas Bechtel; MB Tighe; SA Ezzone; MD Scholl; P S Belt; Donn C Young; Belinda R Avalos
The influence of early transplantation, age, GVHD prevention regimen, and other factors on outcome of allogeneic transplantation for CML following BuCy.
Bone marrow transplantation 2000;26(10):1037-43.
2000: Edward A Copelan; Sam Penza; Brad Pohlman; Belinda R Avalos; Marlene Goormastic; Steven Andresen; Matt Kalaycio; Thomas Bechtel; MD Scholl; Patrick J Elder; SA Ezzone; Lynn C O'Donnell; MB Tighe; G L Risley; Donn C Young; Brian J Bolwell
Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphoma.
Bone marrow transplantation 2000;25(12):1243-8.
2000: Edward A Copelan; Sam Penza; Patrick J Elder; SA Ezzone; MD Scholl; Thomas Bechtel; P S Belt; Belinda R Avalos
Analysis of prognostic factors for allogeneic marrow transplantation following busulfan and cyclophosphamide in myelodysplastic syndrome and after leukemic transformation.
Bone marrow transplantation 2000;25(12):1219-22.
1997: Edward A Copelan; S K Ceselski; SA Ezzone; Larry C Lasky; Sam Penza; Thomas Bechtel; J L Klein; D M Hehmeyer; MD Scholl; D D Marshall; Patrick J Elder; G L Risley; Belinda R Avalos
Mobilization of peripheral-blood progenitor cells with high-dose etoposide and granulocyte colony-stimulating factor in patients with breast cancer, non-Hodgkin's lymphoma, and Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):759-65.